πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe β€” phase, modality, and trial IDs.

Programs
1,032

Quick answer

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. TransCon PEG treprostinil

    United Therapeutics Europe Ltd

    PAH

    phase 1 small molecule terminated

    1 trial

  2. Treprostinil Inhalation Powder

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule completed

    1 trial

  3. Treprostinil diethanolamine

    United Therapeutics Europe Ltd

    Hypertension, Pulmonary

    phase 1 small molecule completed

    2 trials

  4. UB-221

    United Therapeutics Europe Ltd

    Urticaria Chronic

    phase 1 mab completed

    1 trial

  5. UB-221

    United Therapeutics Europe Ltd

    Chronic Idiopathic Urticaria

    phase 1 small molecule active

    1 trial

  6. UB-421 SC

    United Therapeutics Europe Ltd

    HIV-1-infection

    phase 1 mab active

    1 trial

  7. UB-421 SC(dB4C7C22-6 mAb)

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 1 mab completed

    1 trial

  8. UB-621

    United Therapeutics Europe Ltd

    Herpes Simplex Virus Infection

    phase 1 small molecule completed

    1 trial

  9. UB-921

    United Therapeutics Europe Ltd

    Breast Neoplasm

    phase 1 mab completed

    1 trial

  10. UI009

    United Therapeutics Europe Ltd

    Health

    phase 1 small molecule completed

    1 trial

  11. UI059

    United Therapeutics Europe Ltd

    Gastro-Intestinal Disorder

    phase 1 small molecule active

    1 trial

  12. UI059

    United Therapeutics Europe Ltd

    GERD

    phase 1 small molecule completed

    1 trial

  13. UI15AML055MT

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  14. UIC201602 and co-administration of UIC201601 and UIC201602

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  15. UKidney

    United Therapeutics Europe Ltd

    Kidney Failure, Chronic

    phase 1 other terminated

    1 trial

  16. UNEX-42

    United Therapeutics Europe Ltd

    Bronchopulmonary Dysplasia

    phase 1 mab terminated

    1 trial

  17. USB005 (aclerastide) Ophthalmic Solution

    United Therapeutics Europe Ltd

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  18. UT-15C

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    2 trials

  19. UT-15C SR (treprostinil diethanolamine)

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule completed

    1 trial

  20. V920

    United Therapeutics Europe Ltd

    Ebola Virus

    phase 1 mab completed

    1 trial

  21. VS-6766

    United Therapeutics Europe Ltd

    NSCLC

    phase 1 small molecule active

    1 trial

  22. Vaccine/device combination for prevention of HFRS

    United Therapeutics Europe Ltd

    Hemorrhagic Fever With Renal Syndrome

    phase 1 mab completed

    1 trial

  23. Venezuelan Equine Encephalitis DNA Vaccine

    United Therapeutics Europe Ltd

    Vaccine Reaction

    phase 1 small molecule active

    1 trial

  24. WX-UK1 in combination with Capecitabine

    United Therapeutics Europe Ltd

    Advanced Malignancies

    phase 1 small molecule completed

    1 trial

  25. [123I] IBVM and SPECT imaging

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  26. [18F]-Ξ±vΞ²6-BP

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 1 small molecule active

    1 trial

  27. acetylsalicylic acid

    United Therapeutics Europe Ltd

    Precancerous Condition

    phase 1 small molecule completed

    1 trial

  28. acupuncture

    United Therapeutics Europe Ltd

    Migraine Headaches

    phase 1 other completed

    1 trial

  29. administration of UI018

    United Therapeutics Europe Ltd

    Hyperlipemia, Mixed

    phase 1 small molecule active

    1 trial

  30. administration of UI058

    United Therapeutics Europe Ltd

    GERD

    phase 1 small molecule completed

    1 trial

  31. administration of UI068

    United Therapeutics Europe Ltd

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial

  32. cNP8

    United Therapeutics Europe Ltd

    Burns

    phase 1 small molecule completed

    1 trial

  33. d-cycloserine

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    phase 1 small molecule active

    1 trial

  34. engineered autologous T cells

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 mab active

    1 trial

  35. hypo-fractionated SRS

    United Therapeutics Europe Ltd

    Metastatic Cancer

    phase 1 other completed

    1 trial

  36. iC9.GD2.CAR.IL-15 T Infusion

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 1 mab active

    1 trial

  37. iC9.GD2.CAR.IL-15 T-cells

    United Therapeutics Europe Ltd

    Neuroblastoma

    phase 1 mab active

    1 trial

  38. iNexinβ„’ (0.08% aCT1)

    United Therapeutics Europe Ltd

    Dry Eye Disease

    phase 1 small molecule completed

    1 trial

  39. limonene containing massage oil

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 other completed

    1 trial

  40. milatuzumab

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Cutaneous

    phase 1 small molecule completed

    1 trial

  41. olaparib

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  42. oral treprostinil

    United Therapeutics Europe Ltd

    Raynaud's Phenomenon

    phase 1 small molecule completed

    1 trial

  43. pTVG-HP with rhGM-CSF

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 mab completed

    1 trial

  44. removal of omentum

    United Therapeutics Europe Ltd

    Diabetes Mellitus Type 2

    phase 1 other completed

    1 trial

  45. treatment A

    United Therapeutics Europe Ltd

    Dyslipidemia

    phase 1 small molecule active

    1 trial

  46. treprostinil diethanolamine

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule completed

    2 trials

  47. zelenirstat

    United Therapeutics Europe Ltd

    Relapsed Adult AML

    phase 1 small molecule active

    1 trial

  48. 0.1% bupivacaine

    United Therapeutics Europe Ltd

    Pregnancy

    approved small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.